The antibody responses of subjects who presented with a definite Ixodes scapularis (Say) tick bite were measured to determine the utility of the antibody response against recombinant tick calreticulin (rTC) as a biologic marker of tick exposure. Subjects bitten by /. scapularis evidenced an increase in antj-rTC antibody levels between visit 1 and visit 2 from 24.3 to 27.1 ng/uJ serum (n = 88, p = 0.003), and levels remained elevated at visit 3 (p = 0.005). These anti-rTC antibody levels during visits 2 and 3 were significantly higher than those in four non-exposed controls. Tick engorgement indices, measured on the biting ticks, were found to be correlated with anti-rTC antibody levels (e.g., for visit 3: Pearson's r= 0.357, p = 0.001). Tick engorgement index (TEI), ratio of body length to scutal width, was identified to be the only independent predictor of anti-rTC antibody levels in linear regression models. Logistic regression revealed that a bite from an /. scapularis tick that became engorged (TEI >3.4) was a risk factor for anti-rTC antibody seropositivity (adjusted odds ratio for age and bite location = 7.4 (95% confidence interval 2.1-26.4)). The anti-rTC antibody test had a sensitivity of 0.50 and a specificity of 0.86 for a bite from /. scapularis that became engorged. Immunoblotting revealed that subjects made a specific anti-rTC antibody response. Am J Epidemiol 1999;149:777-84, antibody; biologic marker; Ixodes; Lyme disease; tick
In epidemiologic research, host antibody responses to pathogens are commonly used to assess exposure and disease risk. Studies show humans and animals produce antibodies to salivary proteins from various blood feeding arthropods, including mosquitoes (1), biting flies (2) , and ticks (3) . In ticks, salivary glands are the largest glands and perform a variety of impor-tant functions that assist feeding and inhibit the host immune response (4-7). Many tick saliva proteins have been shown to be immunogenic to mammalian hosts (4) .
Previous studies suggest antibodies to tick salivary gland proteins are biologic markers of exposure to ticks (8) (9) (10) (11) (12) . For example, levels of anti-tick saliva antibody (ATSA), using sonicated whole Ixodes scapularis Say or Amblyomma americanum L. salivary glands as antigen, are associated with self-reported tick exposure, Lyme disease seroprevalence, and an index of tick engorgement (9) . ATSA levels are inversely associated with self-reported personal protective behaviors and have been found to have a sensitivity of 0.81 and a specificity of 0.56 for a bite by /. scapularis that became engorged (9) .
It was hypothesized that the sensitivity and specificity of ATSA as a biomarker of tick exposure may be improved by measuring the antibody response to a limited number of specific salivary proteins rather than the antibody response to whole sonicated glands. In the present study, the samples from Westchester County, New York, were re-assayed with a newly identified recombinant tick saliva protein (recombinant tick calreticulin, rTC). Calreticulin is a major calciumbinding protein of the endoplasmic reticulum, and it appears to be secreted in the saliva of A. americanum and Dermacentor variabilis Say (13) . The presence of calreticulin has been demonstrated in the salivary glands of /. scapularis (D. Jaworski, UC Irvine, personal communication, 1998), but, as of this writing, it has not been isolated and expressed for use in biomarker assays. Calreticulin is not detectable in the salivary glands of unfed ticks, but is observable by the third day of feeding (13) .
Anti-rTC antibodies are produced by animals experimentally fed upon by D. variabilis ticks (12) . In contrast, gerbils exposed to Aedes aegypti did not develop detectable levels of anti-rTC antibodies. Anti-rTC antibody seropositivity also was associated with selfreported protective behaviors and fort of origin in military personnel on maneuvers in areas at Fort Chaffee, Arkansas, that were infested with A. americanum (12) . These observations all suggest that anti-rTC antibody is a biologic marker of tick exposure and that this recombinant tick salivary gland protein can be used in the place of whole tick sab'vary glands in the measurement of antibodies to tick salivary gland proteins.
This study examines the kinetics of anti-rTC antibody levels in subjects from Westchester County, New York, with a recent and confirmed tick bite and normal controls. Subjects were part of a randomized trial of empiric antibiotic treatment to prevent Lyme disease after a definite /. scapularis bite in Westchester County, New York. Tick bite subjects retained their ticks and submitted them for acarologic assessment, allowing analysis of anti-rTC antibody response relative to a number of acarologic variables.
MATERIALS AND METHODS

Study population
The study population has been previously described (9) . Briefly, subjects were recruited from Westchester County, New York, an area hyperendemic for Lyme disease transmission (14) . In this study, three subsets of study subjects were examined: 1) persons with a recent (removed <72 hours before blood specimen obtained) /. scapularis bite (n = 95), 88 of whom provided a tick that was suitable for determination of the tick engorgement index, 2) persons with erythema migrans (n = 7), and 3) normal controls without history of tick bite (n = 4). Subjects had three blood samples collected over approximately 6 weeks.
Antigen preparation
Recombinant tick calreticulin (rTC) was prepared as described previously (Raha et al., unpublished manuscript). Briefly, a truncated A. americanum calreticulin cDNA clone (missing 90 base pairs of the 5' end) was subcloned into pRSETB (Invitrogen, San Diego, California) and used to transform TOPP 5 cells (Stratagene, La Jolla, California). Expression and purification of the fusion protein was accomplished by the protocols provided by Invitrogen. A single colony was grown in LB medium at 30°C. Cells in the exponential growth phase were heat induced at 42°C for 30 minutes, then grown at 37°C for 2 hours. Cells were harvested by centrifugation and lysed in guanidinium buffer. The guanidinium was removed using a Centriprep 3 (Amicon, Beverly, Massachusetts) and the protein was purified over a nickel column (immobilized anion chromatography).
Study variables
Study variables included demographic characteristics of study subjects, time since tick removal, estimated time from initial attachment of tick to acquisition of blood specimens, study group (/. scapularis bite, erythema migrans, nonexposed control), and several study variables such as tick type, stage, tick engorgement index (TEI), i.e., ratio of body length to scutum width (15) , history of prior tick bite, history of clinical Lyme disease, self-reported second tick bite during the study period, and attachment site.
Human anti-rTC antibody ELISA
All serologic assays were conducted without knowledge of the status of the study subject, and all samples for a given study subject were assayed on the same plate. Enzyme-linked immunosorbent assay (ELISA) plates were coated with 0.2 mg rTC (in 100 (ll phosphatebuffered saline (PBS)) per well overnight at 4°C. The plates were blocked with blotto (2 percent nonfat milk in PBS) for 90 minutes at 37°C. Sera were diluted 1:200 in blotto and 100 microliters per well was incubated overnight at 4°C. After washing, a 1:1000 dilution of goat anti-human immunoglobulin G (IgG) conjugated to horseradish peroxidase (The Binding Site, San Diego, California) in blotto was added to the plates and incubated for 75 minutes at 37°C. The plates were developed with ABTS (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD) and the optical density (OD) measured at 405 nm. The serum concentration of human anti-rTC antibody in ng/(0.1 (nanograms per microliter) was determined based on a kinetic measure of anti-rTC antibody ELISA OD using a VAX kinetic plate reader (Molecular Devices, Sunnyvale, California). Values obtained from the kinetic measure of ELISA OD were adjusted for background and converted to nanograms of human IgG per microliter human serum using a standard curve of known human IgG concentrations.
Statistical analysis
Analyses were performed with BMDP statistical software programs (16) . Descriptive analyses were performed on all study variables. Analysis of variance was used to compare the mean anti-rTC antibody levels in the different subject groups. Pearson's correlation (r) was used to examine the association between pairs of continuous variables. Paired Mests were used to evaluate changes in anti-rTC antibody levels over time.
Multiple linear regression was used to model antirTC antibody response as a function of the human-and tick-derived study variables. Analyses involving the engorgement index were performed only on the subjects with an /. scapularis bite when an engorgement index was obtained (n = 88).
Anti-rTC antibody levels were dichotomized at the 75th percentile of the anti-rTC antibody distribution, dividing tick bite subjects into "positive" and "negative" anti-rTC antibody serologic results. The 75th percentile of the distribution corresponded to the mean anti-rTC antibody level plus 4.9 standard deviations of the four control subjects. Subsequently, stratified analysis and logistic regression were used to identify risk factors for anti-rTC antibody seropositivity. Continuous variables were dichotomized so that odds ratios and 95 percent confidence intervals could be determined.
The sensitivity and specificity of anti-rTC antibody serologic status were calculated for individuals with a tick engorgement index of ^3.4 (75th percentile of the TEI distribution) compared with those with TEI below this cutoff. Experiments in animals suggest that a TEI of 3.4 corresponds to an experimental feeding duration of 69 hours for nymphal /. scapularis and 50 hours for adult /. scapularis (17) .
domly selected, and sera from each of their three visits were used. The NC strips were washed with PBST and incubated for one hour with rocking at room temperature with horseradish peroxidase labeled goat antihuman IgG (gamma chain specific) (the Binding Site, San Diego, California), diluted 1:1,000 in blotto. The NC strips were washed with PBST and PBS, and then developed with 4-chloro-l-naphthol (4CN Peroxidase Substrate, Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD).
RESULTS
Of the 95 subjects bitten by /. scapularis, five developed symptoms compatible with clinical Lyme disease, nine reported a prior diagnosis of Lyme disease, 27 reported a prior tick bite, and 17 reported receiving a second tick bite during the study period (table 1) . Of the /. scapularis ticks with a measured TEI, approximately 57 percent were nymphs and 43 percent were adult females.
Anti-rTC antibody levels increased over time
Mean anti-rTC antibody levels were higher in tick bite subjects than in controls for visits 2 and 3; there was no significant difference between tick bite subjects and controls for visit 1 (table 2) . Subjects with erythema migrans had significantly higher anti-rTC antibody levels for visits 2 and 3 compared with controls, but not for visit 1. In subjects who were bitten by a tick with a measurable TEI, mean anti-rTC antibody levels were significantly higher at visits 2 and 3 compared with visit 1; there was no significant difference between visits 2 and 3 (table 2) . Erythema migrans subjects demonstrated a similar result, while control subjects evidenced no change over time.
Immunoblotting
Approximately 40 |ig of rTC was electrophoresed by SDS-PAGE on a pre-cast, 4-20 percent polyacrylamide gradient denaturing mini-gel (Jules Biotechnology, New Haven, Connecticut). Proteins were transferred to a nitrocellulose (NC) membrane (Trans-Blot, Bio-Rad Laboratories, Hercules, California) in a Mini-Protean II Electrophoresis/Transfer Unit (Bio-Rad Laboratories) containing 192 mM glycine, 89 mM Tris, and 20 percent (v/v) methanol in distilled water, at 4°C, for 3.5 hours at 170 mA.
Following transfer, the NC membrane was cut into 4 mm wide strips and blocked with blotto. The NC strips were incubated with human sera (diluted 1:100 in blotto) overnight at 4°C with rocking. Three tick bite subjects with a tick on which TEI was measured were ran- t ELISA, enzyme-linked immunosorbent assay; Cl, confidence interval; TEI, tick engorgement index, ratio of body length to scutal width, i p value for paired Mest comparing mean anti-rTC antibody levels from visit 1 and 2, visit 1 and 3, and visit 2 and 3. § Visit 3: n = 78, 10 individuals had no sera collected for visit 3. # These anti-rTC antibody levels were statistically significantly different from levels in the controls from the same study visit.
TEI Is correlated with anti-rTC antibody levels
TEI was found to be correlated with anti-rTC antibody levels for all three visits (table 3 and figure 1) . A previous study found that engorgement index was correlated with ATSA levels (9), and those data are shown for comparison in table 3. ATSA levels were poorly correlated with the corresponding anti-rTC antibody levels for all visits (table 2).
Predictors of anti-rTC antibody levels
The anti-rTC antibody levels at visit 3, the change in the antibody levels between visits 1 and 2 and the change in the antibody levels between visits 1 and 3 were modeled using linear regression. TEI was found to predict anti-rTC antibody levels during all three visits. No other variables were found to be associated with the anti-rTC antibody levels when added to the linear regression models. No study variables were found to predict the change in anti-rTC antibody levels over time. 
Risk factors for anti-rTC seroposltivlty
TEI was divided into quartiles (<2.45, 2.46-2.71, 2.72-3.4, and >3.4) and associations between TEI and anti-rTC antibody levels were examined (table 4) . Subjects who were bitten by a tick with a TEI between 2.72 and 3. Logistic regression next was used to model the association between anti-rTC antibody seropositivity and TEI, controlling for age (<46 vs. >46 years; median age = 46 years) and other confounding variables (table  5) . For these analyses, TEI was dichotomized at 3.4, the 75th percentile in its distribution. Only location of tick bite was associated with anti-rTC antibody seropositivity. Using the four most common bite locations (thigh, forearm, arm, and groin) compared with all other locations, only the thigh was found to be significantly associated with seropositivity for anti-rTC antibody. When tick bite location was added to the model, the odds ratio for the association of TEI with anti-rTC antibody seropositivity increased to 7.4 (95 percent Cl 2.1-26.4). Individuals who were bitten on the thigh had a 12-fold increased risk of seropositivity for anti-rTC antibody (OR = 12.4, 95 percent Cl 2.54-61.0).
Sensitivity and specificity of anti-rTC antibody test
Anti-rTC antibody seropositivity as a test to identify a subject bitten by a tick that became engorged (TEI >3.4) had a sensitivity of 50 percent and a specificity of 86 percent. • Defined as 75th percentile in distribution of anti-rTC antibody levels, 4.9 SDt above mean of four subjects without a history of tick bites.
t Cl, confidence interval; TEI, tick engorgement index, ratio of body length to scutal width; SD, standard deviation.
% Adjusted for age and bite location. § A TEI £3.4 was the 75th percentile in the TEI distribution.
Immunoblots
Immunoblots using rTC as antigen were performed in order to determine the analytical specificity of the antibody response detected by ELISA ( figure 2 ). All of the tested human serum samples had IgG that recognized a band of approximately 64 kDa for all three visits. Little qualitative difference in band intensity between time points was observed in any of the three subjects; no quantitative measurements of band intensity were made. The results indicate that the antibody response made by humans, as measured by ELISA, appears to include specific anti-rTC antibody.
DISCUSSION
The present study describes associations between anti-rTC antibody seropositivity and several acarologic variables. While several similarities exist between antirTC antibody and ATSA, a previously described bio- Immunoblots of sera of three human subjects bitten by /. scapularis using rTC as antigen. All subjects provided ticks which had measured tick engorgement index (TEI); only subject 1 was bitten by a tick which became engorged (TEI >3.4). Lanes 1, 2, and 3: subject 1, visits 1, 2, and 3, respectively; lanes 4, 5, and 6: subject 2, visits 1, 2, and 3, respectively; lanes 7, 8, and 9: subject 3, visits 1, 2, and 3, respectively.
logic marker of tick exposure, the present study demonstrates that anti-rTC antibody levels increase after a single tick bite. Anti-rTC antibody seropositivity also has lower sensitivity and higher specificity, compared with ATSA, to identify subjects bitten by a tick that became engorged. These results demonstrate that there are differences between the host antibody response directed against rTC and that directed against ATSA.
Anti-rTC antibody levels increased during the time from visit 1 to visit 2 (approximately 3 weeks) in study subjects bitten by a tick with a determined TEI. This group was also shown to have significantly higher levels of anti-rTC antibody than nonexposed controls during visits 2 and 3. Although the tick bite subjects had higher anti-rTC antibody levels than nonexposed controls at visit 1, this difference was not statistically significant. The increase in levels of specific anti-rTC IgG antibody over time demonstrates that rTC is recognized by the immune system of the study subjects after a bite from a feeding tick, probably representing secondary exposure to ticks in this hyperendemic area.
Subjects who reported erythema migrans (« = 7) were part of a second study and did not have ticks available for measurement of TEI. This group demonstrated an increase in anti-rTC antibody levels similar to that of the larger group who were bitten by a tick on which TEI was measured (n = 88). Erythema migrans would be indicative of a recent, longer duration tick bite, and thus these individuals would be expected to develop anti-rTC antibody levels similar to those subjects with observed recent tick bite.
Immunoblots of individuals reveal that humans make a specific anti-rTC antibody response. This result is similar to previous anti-rTC antibody immunoblots done with human sera (12) , which found that study subjects from Fort Chaffee, Arkansas, visualized a band at approximately 64 kDa, the molecular weight of rTC. TEI, measured from ticks removed from study subjects, was shown to be correlated with anti-rTC antibody levels at all three visits. When four subjects with high TEI but low anti-rTC antibody levels were removed from the scatterplot, the Pearson's r increased to 0.493 (p = 0.001). It is possible that inter-species differences in calreticulin could explain those results. The recombinant tick calreticulin used in this study was cloned from the salivary glands of A. americanum (13) , and is, to our knowledge, the only recombinant tick saliva protein available. As stated above, subjects in the current study were bitten by /. scapularis. Individuals with long duration tick bites from /. scapularis (high TEI) may not develop high levels of antirTC antibodies to A. americanum derived calreticulin, depending on the extent of their cross-reactivity. In addition, antibodies produced by subjects in the current study were produced in response to a bite from /.
Am J Epidemiol Vol. 149, No. 8, 1999 Anti-Tick Calreticulin Antibody: A Biomarker of Tick Bites 783 scapularis, but the rTC used was obtained from A. americanum. It is possible that anti-/. scapularis antibodies only recognize a subset of cross-reactive epitopes on the A. americanum derived calreticulin, thereby affecting the ability to detect intensity differences based on immunoblotting.
In a previous study of a biologic marker of tick exposure in the same study population (9) , TEI was shown to be a predictor of ATS A levels. In that study, ATSA levels did not increase significantly over time, in contrast to anti-rTC antibody levels. In the current study, ATSA and anti-rTC antibody levels were poorly correlated, although both were correlated with TEI. The lack of correlation between the two biologic markers (r = -0.017 to -0.045 for the three visits) was found to be influenced by six individuals with high levels of anti-rTC antibody and low ATSA levels. When these six subjects were dropped from the analysis, the Pearson's r increased to 0.22 (p = 0.071). In five out of these six subjects (83.8 percent), the biting tick was a nymph; this value could be compared with the 55.6 percent of the remaining tick bite subjects who were bitten by a nymph. It is possible that there are differences in calreticulin kinetics in the saliva of adult ticks in contrast to nymphal ticks, accounting for this observation. A dose-response effect may also account for the antibody response of these subjects; nymphal ticks may secrete smaller amounts of saliva overall, resulting in a lower ATSA response, but the proportion of calreticulin in the saliva may be higher, resulting in an increased anti-rTC antibody response. This is speculative and further work is needed to characterize the dynamics of calreticulin production in the salivary glands of immature and adult ticks.
The sensitivity and specificity of the anti-rTC antibody serologic test can be compared with the sensitivity and specificity of ATSA determined in a previous study. ATSA was found to have a sensitivity of 0.81 and a specificity of 0.56 to identify individuals bitten by an /. scapularis that became engorged (TEI >3.4). The current study revealed that anti-rTC antibody seropositivity had a sensitivity of 0.50 and a specificity of 0.86 to identify individuals after the same tick bite. As opposed to ATSA, anti-rTC antibodies are raised against a specific recombinant tick protein. Because the rTC has no carbohydrate epitopes, and is a single isolated tick protein, the amount of potential crossreactivity is greatly reduced. This would reduce the number of false positive results due to cross-reactivity, thus increasing the specificity of the assay. Tick calreticulin has also been shown to be undetected in tick salivary glands until after approximately 3 days of attachment (13) . Anti-rTC antibody seropositivity would therefore be expected in a smaller subset of tick bite subjects, those with longer duration bites, and would have far less potential for cross-reactivity resulting in decreased sensitivity and increased specificity compared with ATSA seropositivity.
In terms of practical application, the two tests could be used together in a parallel testing technique, producing results that would be over 80 percent sensitive and specific for an /. scapularis bite which became engorged. Anti-vector antibody tests would be particularly useful in situations where the anti-vector borne pathogen test has low sensitivity. For example, serologic tests for anti-fi. burgdorferi antibody have sensitivities <50 percent in the early stages of Lyme disease. An assay (or combination of assays) with high sensitivity and specificity for tick bites conferring Lyme disease risk (duration >48 hours) may assist in assessing risk of early Lyme disease. It is probable that anti-arthropod saliva antibody assays are primarily useful as research tools for the study of arthropod exposure. Additional research is necessary to determine if these assays will have clinical utility. In a patient presenting with symptoms compatible with a tick-borne disease, a diagnostic test that confirms a recent tick bite may assist the clinician. However, there are several host-, vector-, and pathogen-related factors that must first be elucidated. For example, it has been demonstrated (19) that nymphal /. scapularis ticks can transmit Lyme disease to mice in less than 48 hours, and the dynamics of calreticulin in the saliva of nymphal ticks has yet to be described.
Currently, the study of vector borne disease epidemiology lacks reliable biologic markers of arthropod exposure, and therefore relies heavily on selfreporting as a measure of exposure to arthropod vectors, especially ticks. Self-reporting of tick bites has been shown to be a poor indicator of tick bites (18) . A biologic marker of tick bites would allow for a more accurate measure of tick exposure, both at the population level and at the individual level. This would improve the study of tick exposure in epidemiologic studies, as well as providing a possible mechanism for the estimation of individual risk of tickborne disease after tick bites.
Anti-rTC antibody may be a more specific biomarker of tick bites than ATSA, although ATSA has been shown to have greater sensitivity. Used together, the two assays may have the potential for improving the detection of long-duration (>48 hours) tick bites in human subjects through an adequate balance of sensitivity and specificity. The development of recombinant tick salivary gland proteins for other tick species may lead to even more specific biomarkers of tick bites and an increase in the utility of anti-tick salivary protein antibodies in the diagnosis of tickborne disease.
